The Relief Therapeutics (OTCMKTS:RLFTF) stock was one of the notable movers this past week and ended up with gains of 10%.
There was no specific news about the company last week but the rally might have been triggered by an announcement from the company last week. Last week, the company had announced that, along with its partner NRx Pharmaceuticals, it had applied for an emergency use authorization for its product Zyesami.
The product is meant for the treatment of critically ill COVID 19 patients. It is a significant development for Relief and the market recognised the importance of the development. The latest report was in line with the top line data that had been previously published by the developers. The study revealed a statistically significant improvement n the conditions of patients who had been suffering from COVID 19 related respiratory failures. Investors could do well to keep the stock in their watch lists at this point.
Moving Averages
| +/- EMA(20) | 0.24 (+8.33%) |
| +/- SMA(50) | 0.25 (+4.00%) |
| +/- SMA(200) | 0.40 (-35.00%) |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
| Classic | 0.2384 | 0.2442 | 0.2526 | 0.2584 | 0.2668 | 0.2726 | 0.2810 |
| Fibonacci | 0.2442 | 0.2496 | 0.2530 | 0.2584 | 0.2638 | 0.2672 | 0.2726 |
 Stock Continues to Move Up: Buy It or Sell It?){kind=link}